Close

GARP Research Maintains a 'Buy' on Rosetta Stone (RST); Horrible Quarter; Reluctantly Keeping Rating

March 3, 2011 10:05 AM EST Send to a Friend
GARP Research maintains a 'Buy' on Rosetta Stone (NYSE: RST), PT $13.

GARP analyst says, "We are maintaining our Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login